We are live on ! Find out more
TBPH icon

Theravance Biopharma
TBPH

107 hedge funds and large institutions have $946M invested in Theravance Biopharma in 2020 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 33 increasing their positions, 32 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

6,800% more call options, than puts

Call options by funds: $69K | Put options by funds: $1K

22% more capital invested

Capital invested by funds: $775M → $946M (+$170M)

3% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 32

0.62% more ownership

Funds ownership: 82.6% → 83.21% (+0.62%)

9% less funds holding

Funds holding: 118 → 107 (-11)

42% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 26

Holders
107
Holders Change
-11
Holders Change %
-9.32%
% of All Funds
1.89%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
15
Increased
33
Reduced
32
Closed
26
Calls
$69K
Puts
$1K
Net Calls
+$68K
Net Calls Change
+$230K

Top Buyers

Rank Fund Capital Flow
1
GPP
Great Point Partners
Connecticut
+$14.8M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$13.3M
3
LCM
Laurion Capital Management
New York
+$11.2M
4
Morgan Stanley
Morgan Stanley
New York
+$8.39M
5
BlackRock
BlackRock
New York
+$3.08M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$10.3M
2
RCMNY
Rubric Capital Management (New York)
New York
-$8.14M
3
Norges Bank
Norges Bank
Norway
-$6.32M
4
RSCM
Rock Springs Capital Management
Maryland
-$2.62M
5
Citadel Advisors
Citadel Advisors
Florida
-$2.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
CHA
101
Carmichael Hill & Associates
Maryland
$1K – – –
PCFFS
102
Pacific Center for Financial Services
California
$1K – – –
S
103
SignatureFD
Georgia
$1K – – –
AIG
104
American International Group
New York
$482 -$6.98K -389 -1%
Adage Capital Partners
105
Adage Capital Partners
Massachusetts
– -$10.3M -700,000 Closed
RCMNY
106
Rubric Capital Management (New York)
New York
– -$8.14M -550,747 Closed
Citadel Advisors
107
Citadel Advisors
Florida
– -$2.2M -148,752 Closed
HP
108
Hound Partners
New York
– -$846K -57,200 Closed
Squarepoint
109
Squarepoint
New York
– -$738K -49,919 Closed
AAMU
110
Amundi Asset Management US
Massachusetts
– -$698K -47,182 Closed
First Trust Advisors
111
First Trust Advisors
Illinois
– -$645K -43,608 Closed
Two Sigma Investments
112
Two Sigma Investments
New York
– -$584K -39,519 Closed
Voloridge Investment Management
113
Voloridge Investment Management
Florida
– -$516K -34,899 Closed
Jane Street
114
Jane Street
New York
– -$313K -21,140 Closed
HF
115
HRT Financial
New York
– -$311K -21,083 Closed
ECM
116
ExodusPoint Capital Management
New York
– -$273K -18,472 Closed
Qube Research & Technologies (QRT)
117
Qube Research & Technologies (QRT)
United Kingdom
– -$253K -17,094 Closed
GCP
118
GSA Capital Partners
United Kingdom
– -$206K -13,965 Closed
TI
119
Trexquant Investment
Connecticut
– -$195K -13,167 Closed
MAM
120
Martingale Asset Management
Massachusetts
– -$166K -11,200 Closed
Lazard Asset Management
121
Lazard Asset Management
New York
– -$120K -8,156 Closed
QT
122
Quantbot Technologies
New York
– -$99K -6,700 Closed
AIM
123
Aigen Investment Management
New York
– -$69K -4,663 Closed
CM
124
Caption Management
Oklahoma
– -$65K -4,400 Closed
SPIA
125
Steward Partners Investment Advisory
New York
– -$7K -500 Closed
2 3 4
5
6

TBPH Hedge Fund Activity: Q4 2020 in Review

107 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Theravance Biopharma (TBPH) for Q4 2020, worth a combined $946M — up 22% from $775M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of TBPH and 15 opened new positions — a net loss of 11 holders — while 32 trimmed existing stakes and 33 added.

The largest buyer was Great Point Partners, opening a new position worth an estimated $14.8M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $10.3M sold.

  • 107 institutional investors held Theravance Biopharma (TBPH) as of Q4 2020, down from 118 in Q3 2020.
  • Funds reported $946M of Theravance Biopharma stock for Q4 2020, up 22% quarter-over-quarter.
  • 15 funds opened new Theravance Biopharma positions in Q4 2020 and 26 closed out, a net change of -11 holders.
  • The largest Theravance Biopharma buyer in Q4 2020 was Great Point Partners, an estimated $14.8M added.
  • The largest Theravance Biopharma seller in Q4 2020 was Adage Capital Partners, an estimated $10.3M sold.

Based on aggregated 13F filings for Q4 2020.